Non-medical Switching from Originator Tumor Necrosis Factor Inhibitors to Their Biosimilars: Systematic Review of Randomized Controlled Trials and Real-World Studies
Crossref DOI link: https://doi.org/10.1007/s12325-018-0742-9
Published Online: 2018-08-06
Published Print: 2018-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Numan, Syed
Faccin, Freddy
Funding for this research was provided by:
AbbVie
Article History
Received: 14 May 2018
First Online: 6 August 2018